Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon gamma-1b for steroid-refractory bronchiolitis obliterans after allogeneic stem cell transplantation
2010-022467-36Phase 2Completed
- Sponsor
- Free State of Bavaria
- Start
- Jun 2011
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of interferon gamma-1b in Bronchiolitis Obliterans (BO) and airway morbidity, sponsored by Free State of Bavaria. Primary endpoints: lung function testing and blood gas analysis. Started Jun 2011; status: completed.
02
Drugs
interferon gamma-1b
03
Conditions
Bronchiolitis Obliterans (BO)airway morbidity
Beyond the preview
Go deeper on 2010-022467-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022467-36.